This whole cholestrol/lipid thing is certainly a factor in the sale of statins. Problem is “risk” is a relative thing and statins have side effects for sure.
Newsmachete provides a pretty good review of the situation.
He displays a heatlhy amount of skepticism.
I am sure Ernest Curtis will cooment favorably on the Newsmachete essay.